1-5 of 5
Johan Lund
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel Biosignature for Potential Stratification and Elucidation of Newly Diagnosed Multiple Myeloma Patients at-Risk

Muhammad Kashif, Yijie Zhou, Vincent Luong, Katarina Uttervall, Gösta Gahrton, Hareth Nahi, Evren Alici, Johan Lund
Journal: Blood
Blood (2023) 142 (Supplement 1): 1960.
https://doi.org/10.1182/blood-2023-179999
Published: 2023
Journal Articles

Alnuctamab (ALNUC; BMS-986349; CC-93269), a B-Cell Maturation Antigen (BCMA) x CD3 T-Cell Engager (TCE), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from a Phase 1 First-in-Human Clinical Study

Sandy W. Wong, Noffar Bar, Laura Paris, Craig C Hofmeister, Markus Hansson, Armando Santoro, Maria-Victoria Mateos, Paula Rodríguez-Otero, Johan Lund, Cristina Encinas, Andrew J. Yee, Albert Oriol, Claudio Cerchione, Javier de la Rubia, Barbara Ferstl, Kristina Carlson, Paz Ribas, Arancha Bermúdez, Isaac W. Boss, Allison Gaudy, Shaoyi Li, Kevin Hsu, Colin D. Godwin, Michael R. Burgess, Jesús San-Miguel, Luciano J. Costa
Journal: Blood
Blood (2022) 140 (Supplement 1): 400–402.
https://doi.org/10.1182/blood-2022-159009
Published: 2022
Journal Articles

Teclistamab for Relapsed/Refractory Multiple Myeloma: Real-World Experience in an Early Access Program

Katarina Uttervall, Hareth Nahi, Muhammad Kashif, Konstantinos Lemonakis, Sara Rosengren, Janaki Brolin, Johan Lund, Markus Hansson
Journal: Blood
Blood (2022) 140 (Supplement 1): 12605–12606.
https://doi.org/10.1182/blood-2022-158801
Published: 2022
Journal Articles

The Rev II Trial: Lenalidomide and Dexamethasone As Second Line Treatment in Myeloma Followed By Extended Lenalidomid Vs Len/Dex

Johan Lund, MD, Sigrid Karstorp, MD, Evren Alici, MD PhD, Astrid Gruber, MD PhD, Birgitta Lauri, MD, Cecilie Blimark, MD PhD, Agneta Swedin, MD PhD, Markus Hansson, MD PhD, Karin Forsberg, MD, Lucia Ahlberg, MD, Carlsson Conny, MD, Anders Waage, MD PhD, Peter Gimsing, Annette Juul Vangsted, MD PhD, Ulf Christian Frølund, MD, Mats Hardling, Ulf-Henrik Mellqvist, MD PhD, Hareth Nahi
Journal: Blood
Blood (2015) 126 (23): 3047.
https://doi.org/10.1182/blood.V126.23.3047.3047
Published: 2015
Journal Articles

Re-Challenging with Anti-CD38 Monotherapy in Triple-Refractory Multiple Myeloma Patients Is a Feasible and Safe Approach

Johan Lund, MD, Evren Alici, MD PhD, Michael Chrobok, MD, Astrid Gruber, MD PhD, Tahamtan Ahmadi, Imran Khan, Hareth Nahi
Journal: Blood
Blood (2015) 126 (23): 5366.
https://doi.org/10.1182/blood.V126.23.5366.5366
Published: 2015